Institute of Reproductive Medicine of the University, Domagkstr. 11, D-48149 Münster, Germany
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: AZF/fertility/microdeletion/Y chromosome
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Case report |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Male medical history revealed asthma bronchiale since 1995 (treated with sympathicomimetics and glucocorticoid aerosoles) and a ligation of a left-sided varicocele in 1984. Post-surgery antibiotics were given because of an infection (probably epididymitis). In a first semen analysis performed in 1996 by an outside urologist, mild oligoteratozoospermia with a sperm concentration of 19x106/ml was found. In four further semen analyses a moderate decline in sperm concentration to 6x106/ml was observed. Oral testosterone undecanoate (Andriol 160 mg/d) was prescribed for 4 weeks. Results of physical and genital examination were normal. Testes volume was 17 ml bilaterally. Ultrasonographic examinations of the testes showed homogenous architecture with single echodense areas in both testes.
Semen analysis performed in our institute in July 1998 according to World Health Organization guidelines (World Health Organization, 1992) showed oligoasthenoteratozoospermia [sperm concentration 2.4x106/ml; 37% progressive motility (World Health Organization grade a and b); 11% normal morphology]. FSH, LH and testosterone were in the normal range. Markers for the function of epididymis, seminal vesicles and prostate were in the normal range. We recommended termination of testosterone undecanoate medication, since no positive effects on male infertility had been found in controlled studies (Kamischke and Nieschlag, 1999).
After antibiotic treatment for an infection of the accessory glands in April 1999, semen analysis showed moderate oligoasthenoteratozoospermia (sperm concentration 8.3 x106/ml; 48% progressive motility; 13% normal morphology). A spontaneous pregnancy occurred and a healthy boy without evidence of minor or major malformations was born in April 1999. A control semen analysis performed in February 2002 confirmed moderate oligoasthenoteratozoospermia (sperm concentration: 7x106/ml; 40% progressive motility; 18% normal morphology) with no signs of further deterioration of spermatogenesis.
The patient had two sisters who were 7 and 4 years older than himself. Both sisters had children and no cases of infertility were reported in his family. At the time of the patient's birth, his mother was 29 years old and his father 35 years old. Further information about their reproductive state was not available. However, as the younger sister was 4 years older than the patient, and assuming no active contraception, a maximum time to pregnancy of 3 years can be estimated, indicating that (at this timepoint) no severe fertility problems were present. The patient's father was unwilling to deliver a semen sample when attending our clinic; however, slightly elevated FSH serum levels (7.6 IU/l, normal range for young men 17 IU/l) were found, while LH, testosterone, estradiol, prolactin and sex hormone-binding globulin serum levels were in the normal range.
Because the first semen sample at our institute showed sperm concentrations <5x106/ml and because ICSI treatment was anticipated, we analysed the Y chromosome for microdeletions (Simoni et al., 1998). After we found a deletion in AZFb and when the spontaneous pregnancy occurred, we investigated whether the microdeletion was also found in the patient's son and father.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
To determine the extent of the microdeletion and to investigate whether its length grossly expanded over generations, additional primers, both in the AZFb region (RBM1, sY114, sY127, sY131, sY134, sY135, eIF-1AY, sY 142 and sY602) and in other regions outside the AZFb region (SRY, ZFY and sY95) were used to analyse the DNA of the patient, his father and his son. In addition, the following primers were used only in the patient: sY81, sY82, Y6HP35pr, sY86, sY88, sY182, sY151, sY94, sY95, sY97, sY102, sY109, Y6D14pr, Y6BaH34pr, sY117, Y6PHc54pr, sY153, Fr15-Ilpr, Y6HP52pr, sY157 and sY255.
The deletion of sY130 in the propositum was further analysed by Southern blotting. Genomic DNA (8 µg) was digested with either EcoR1 or BamH1. The restricted DNA was separated by electrophoresis in 0.8% agarose gels and transferred to nylon membranes (Hybond-N; Amersham Pharmacia, Freiburg, Germany) by capillary blot. The filters were baked for 2 h at 80°C to fix the DNA. The blot was prehybridized using ExpressHyb (Clontech, Heidelberg, Germany) for 30 min and hybridized for 1 h 30 min at 60°C. Several washing steps were performed according to the recommendations of the manufacturers and the blot was exposed to Phosphoimager cassettes. The sY130 sequence tagged site (STS) was subcloned into the pGEM-Teasy vector (Promega, Heidelberg, Germany) and its identity was confirmed by DNA sequencing. For labelling purposes the sY130 fragment was removed from the vector by EcoR1 digestion and subsequently labelled with 32dCTP by random priming.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Chang et al. reported a family in which the father transmitted a deletion in the DAZ region to his four sons (Chang et al., 1999). At the time of analysis the father, who had formerly proven his fertility, was azoospermic; the four sons were infertile with azoospermia or severe oligozoospermia. After testicular sperm extraction one son transmitted the deletion to his male newborn. Phenotypic differences of identical mutations in one family and an age-dependent decline of fertility may be causative. The case reported in this paper, however, is the first in which a patient who had inherited a partial deletion in the AZFb region from his father transmitted the deletion to his son spontaneously. We do not know whether the patient's parents used contraceptives. As the two sisters were 7 and 4 years older than the patient, a maximum time to pregnancy in the parents of
2 and 3 years respectively can be estimated, indicating only moderate subfertility at that timepoint. When the patient was born the father was 35 years and the mother 29 years old. Therefore in this case no rapid decline of fertility can be assumed. However, we do not have any information about the reproductive functions of the father to date, as he was not willing to provide a semen sample. At the actual age of 66 years, his serum FSH level was only moderately elevated, therefore severe testicular damage may be considered unlikely.
In one case reported the deletion found in the father was smaller than that of the son (Stuppia et al., 1996), suggesting that some deletions do not necessarily lead to infertility, but that these deletions make the Y chromosome more liable to a second deletion which leads to infertility. In agreement with other data reported previously (Kent-First et al., 1996
; Vogt et al., 1996
; Pryor et al., 1997
; Chang et al., 1999
; Kamischke et al., 1999
; Kleiman et al., 1999
), in the case presented here a probably identical deletion was transmitted over three generations. However, since the region of the Y chromosome in which the deletion is located contains repetitive sequences and the method employed in the present study allows only a rough determination of the boundaries, a minor extension over generations of the deletion not covered by the STS used for AZFb cannot be excluded.
The finding of AZFb deletions in fertile men is a contradictory issue. Pryor et al. found small microdeletions in the AZFb region (deletion site sY207 and sY272) in four of 200 fertile healthy men (Pryor et al., 1997). In addition, one father of an infertile patient with a mutation in the AZFb region had an identical deletion in this region. Today sY207 and sY272 are considered polymorphic markers. Our patient, his father and his son presented a partial microdeletion in the distal part of the AZFb region showing that the loss of this genomic region is compatible with natural fertility. In contrast, Brandell et al. found that the presence of an AZFb deletion is a severely adverse prognostic factor for ICSI based on sperm obtained by TESE (Brandell et al., 1998
) and the analysis of the literature has confirmed that complete AZFb deletions are associated with the absence of mature sperm in the testis (Krausz et al., 2000
; Kleiman et al., 2001
). In our case the partial deletion in the AZFb region was spontaneously transmitted over three generations, indicating that the deletion is compatible with at least some degree of fertility and natural paternity. However, we cannot exclude the possibility that the moderate decrease in sperm count over the years was genetically determined. The medical history reported varicocele treatment and an infection of the accessory glands. In April 1999, after antibiotic treatment, an improvement of semen parameters could be observed, indicating that the reduced semen parameters in this patient could be due to partial obstruction of the efferent ducts. Semen parameters were practically unchanged in February 2002, raising the possibility that the moderate oligoasthenoteratozoospermia in the propositum is not related to his partial AZFb deletion. It is therefore likely that sY130 and sY143 are polymorphic markers with no effect on sperm production. However, without a semen analysis of the father of the propositum, the pathogenetic role of the deletion cannot be evaluated more precisely.
This case suggests that sons of men with deletions in the AZF region should be tested for AZF deletions, even when pregnancy has been achieved spontaneously. Moreover, they should undergo andrological examination in puberty and, possibly, cryopreservation of semen in early adulthood, since we cannot exclude an age-dependent, gradual worsening of spermatogenesis due to the deletion.
![]() |
Acknowledgements |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Notes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Foresta, C., Moro, E. and Ferlin, A. (2001) Y chromosome microdeletions and alterations of spermatogenesis. Endocr. Rev., 22, 226239.
Chang, P.L., Sauer, M.V. and Brown, S. (1999) Y chromosome microdeletion in a father and his four infertile sons. Hum. Reprod., 14, 26892694.
Jiang, M.C., Lien, Y.R., Chen, S.U., Ko, T.M., Ho, H.N. and Yang, Y.S. (1999) Transmission of de novo mutations of the deleted in azoospermia genes from a severely oligozoospermic male to a son via intracytoplasmic sperm injection. Fertil. Steril., 71, 10291032.[ISI][Medline]
Kamischke, A., Gromoll, J., Simoni, M., Behre, H.M. and Nieschlag, E. (1999) Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case report. Hum. Reprod., 14, 23202322.
Kamischke, A. and Nieschlag, E. (1999) Analysis of medical treatment of male infertility. Hum. Reprod., 14 (Suppl.), 123.
Kent-First, M.G., Kol, S., Muallem, A., Ofir, R., Manor, D., Blazer, S., First, N. and Itskovitz-Eldor, J. (1996) The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathers. Mol. Hum. Reprod., 2, 943950.[Abstract]
Kleiman, S.E., Yogev, L., Gamzu, R., Hauser, R., Botchan, A., Paz, G., Lessing, J.B., Yaron, Y. and Yavetz, H. (1999) Three-generation evaluation of Y-chromosome microdeletion. J. Androl., 20, 394398.
Kleiman, S.E., Bar-Shira Maymon, B., Yogev, L., Paz, G. and Yavetz, H. (2001) The prognostic role of the extent of Y microdeletion on spermatogenesis and maturity of Sertoli cells. Hum. Reprod., 16, 399402.
Krausz, C. and McElreavey, K.Y. (1999) Y chromosome and male infertility. Front. Biosci., 4, E1E8.[Medline]
Krausz, C., Quintana-Murci, L. and McElreavey, K. (2000) Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis? Hum. Reprod., 15, 14311434.
Ma, K., Mallidis, C. and Bhasin, S. (2000) The role of Y chromosome deletions in male infertility. Eur. J. Endocrinol., 142, 418430.[ISI][Medline]
Mulhall, J.P., Reijo, R., Alagappan, R., Brown, L., Page, D., Carson, R. and Oates, R.D. (1997) Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum. Reprod., 12, 503508.[ISI][Medline]
Page, D. C., Silber, S. and Brown, L.G. (1999) Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but are likely to transmit the deletion and infertility. Hum. Reprod., 14, 17221726.
Pryor, J.L., Kent-First, M., Muallem, A., Van Bergen, A.H., Nolten, W.E., Meisner, L. and Roberts, K.P. (1997) Microdeletions in the Y chromosome of infertile men. N. Engl. J. Med., 336, 534539.
Saut, N., Terriou, P., Navarro, A., Levy, N. and Mitchell, M.J. (2000) The human Y chromosome genes BPY2, CDY1 and DAZ are not essential for sustained fertility. Mol. Hum. Reprod., 6, 789793
Simoni, M., Gromoll, J., Dworniczak, B., Rolf, C., Abshagen, K., Kamischke, A., Carani, C., Meschede, D., Behre, H.M., Horst, J. and Nieschlag, E. (1997) Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil. Steril., 67, 542547.[ISI][Medline]
Simoni, M., Kamischke, A. and Nieschlag, E. (1998) Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum. Reprod., 13, 17641768.
Simoni, M., Bakker, E., Eurlings, M.C., Matthijs, G., Moro, E., Muller, C.R. and Vogt, P.H. (1999) Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int. J. Androl., 22, 292299.[ISI][Medline]
Stuppia, L., Calabrese, G., Franchi, P.G., Mingarelli, R., Gatta, V., Palka, G. and Dallapiccola, B. (1996) Widening of a Y-chromosome interval-6 deletion transmitted from a father to his infertile son accounts for an oligozoospermia critical region distal to the RBM1 and DAZ genes [letter]. Am. J. Hum. Genet., 59, 13931395.[ISI][Medline]
Vogt, P.H., Edelmann, A., Kirsch, S., Henegariu, O., Hirschmann, P., Kiesewetter, F., Kohn, F.M., Schill, W.B., Farah, S., Ramos, C. et al. (1996) Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum. Mol. Genet., 5, 933943
Vogt,P.H. (1998) Human chromosome deletions in Yq11, AZF candidate genes and male infertility: history and update. Mol. Hum. Reprod., 4, 739744.[Abstract]
World Health Organisation. (1992) Laboratory Manual for the Examination of Semen and SpermCervical Mucus Interaction. 3rd edn, Cambridge University Press, Cambridge, UK.
Submitted on July 12, 2001; resubmitted on March 18, 2002; accepted on May 7, 2002.